Asstomax (7162) Earnings: Operating Revenue Up +39.2% YoY to 6,108 Million Yen, Reports Operating Loss of 819 Million Yen

Asstomax (7162) has released its financial results, reporting operating revenue up +39.2% YoY to 6,108 million yen, representing a significant increase compared to the same period of the previous year. However, on the profit front, the company posted an operating loss of 819 million yen, an ordinary loss of 845 million yen, and a net loss attributable to owners of the parent of 873 million yen. Earnings per share (EPS) stood at -66.44 yen.

Examining the financial foundation and profitability metrics, the equity ratio is 42.6%, the return on equity (ROE) is 25.73%, and the return on assets (ROA) is 9.11%. Additionally, EBITDA stands at 2.64 billion yen, with retained earnings at 1.38 billion yen. Maintaining a balance between financial soundness against interest-bearing debt of 2.09 billion yen and profitability, the market looks toward future earnings recovery.